Full story

Meningitis B jab to be added to NHS child vaccine schedule

11:45am Monday 30th March 2015 content supplied byNHS Choices

"All babies in the UK will soon have a potentially life-saving vaccine against meningitis B," The Guardian reports. The vaccine, Bexsero, will soon be offered to babies once they reach the age of two months, followed by two more booster shots.


What is meningitis B?

Meningitis B is a highly aggressive strain of bacterial meningitis that infects the protective membranes surrounding the brain and spinal cord. It is very serious and should be treated as a medical emergency. If the infection is left untreated, it can cause severe brain damage and infect the blood (septicaemia). In some cases, bacterial meningitis can be fatal.


How common is meningitis B?

The charity Meningitis Now estimates that there are 1,870 cases of meningitis B each year in the UK. Meningitis B is most common in children under five years old, particularly in babies under the age of one.

Initial signs and symptoms of meningitis B in babies include:

  • a high temperature with cold hands and feet
  • they may feel agitated, but not want to be touched
  • they may cry continuously
  • some children are very sleepy and it may be difficult to wake them up
  • they may appear confused and unresponsive
  • they may develop a blotchy red rash that does not fade when you roll a glass over it

For more information, read about the signs and symptoms of serious illness in babies.


Why is this meningitis B vaccine in the news?

The development of a safe and effective meningitis B vaccine is the culmination of more than 20 years of research and represents a significant breakthrough in disease prevention.


What do we know about the vaccine?

The vaccine, Bexsero, is thought to provide 73% protection against meningitis B, which should significantly reduce the number of cases. The vaccine can be administered to infants aged two months or older either by itself, or in combination with other childhood vaccines.

The vaccine has been tested in clinical trials involving more than 8,000 people.

In infants, it was found to have similar levels of safety and tolerability as other routine childhood vaccines. The most commonly reported side effects were:

  • redness and swelling at the site of the injection
  • irritability
  • fever

It is thought that the vaccine will become available on the NHS in the autumn.


Edited by NHS Choices. Follow Behind the Headlines on Twitter.


"Britain will become the first country in the world to offer a nationwide vaccination programme against meningitis," The Independent reports. A vaccine against the potentially life-threatening bacterial infection will be provided later this year...

Links to Headlines

Meningitis B vaccine added to UK child immunisation scheme. The Guardian, March 29 2015

Now babies WILL get £20 meningitis jab. After year-long row over cost, NHS gives it the nod. Mail Online, March 30 2015

Meningitis B vaccine deal agreed. BBC News, March 30 2015

Every baby to be vaccinated against meningitis B in world first protection programme. Daily Express, March 30 2015

Links to Science


Useful Links

Further Readings

Novartis. Bexsero - Information Leaflet (PDF, 103kb). Published March 2012

National Institute for Health and Care Excellence. Bacterial meningitis and meningococcal septicaemia: Management of bacterial meningitis and meningococcal septicaemia in children and young people younger than 16 years in primary and secondary care. June 2010

Related Videos

Family health interactive guides

Find more interactive guides in our family food section

About cookies

We want you to enjoy your visit to our website. That's why we use cookies to enhance your experience. By staying on our website you agree to our use of cookies. Find out more about the cookies we use.

I agree